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The determination of three‐dimensional structures is now an indispensable part of any study of biological macromolecules, whether the aim is to understand biological phenomena at the molecular level or to develop drugs for controlling such processes. The latter objective is an increasingly important driving force for industrially motivated biostructural research, since the first introduction, in the early 1980s, of a structure‐based drug: captopril, which inhibits the enzyme ACE controlling blood pressure. Protein crystallography and NMR spectroscopy have been used very successfully in "classical" areas of structure‐based drug development, as exemplified by a number of HIV protease inhibitors and by the anti‐influenza agent zanamivir. Furthermore, increasingly complex protein assemblies such as the ribosome ortarget proteins identified in helth threats such as anthrax, tuberculosis, or the SARS virus come now into the focus of structure‐based drug‐design programs. The editors of *Protein Crystallography in Drug Discovery* have identified a gap in the literature and set out to fill it: although there were many recent monographs on protein crystallography and others on the development of drugs in silico, there were very few that dealt with the intersection of these two by discussing specific methods and strategies of protein crystallography in drug design.

As the editors, Robert E. Babine and Sherin S. Abdel‐Meguid, acknowledge in their preface, this multi‐author book of limited size dealing with a wide variety of topics, some of which are very specialized, can only cover a part of the field. Consequently, the work can be divided into two subject areas that are treated to different extents.

The first group of chapters illustrates the present situation in rational drug design, by describing work in six target areas: kinases, proteasomes, ribosomes, cathepsin K, CDK4, and nuclear hormone receptors. These chapters are mostly of a length and style typical of concise, detailed, and informative reviews. However, there are noticeable differences in the authors\' viewpoints regarding rational drug design, depending on whether their background is in academic or industrial research. The chapters on the design of drugs for ribosome and proteasome targets, which have been written by academically oriented scientists, give only rather general and superficial insights into their subjects (perhaps partly because of the complexity of these large‐molecule targets), whereas the contributions from industrial researchers have a somewhat different quality. In these, the authors concentrate on describing in detail the chemical and structural problems that have arisen in different industrial drug‐development programs. It is mainly from these chapters that the reader can appreciate the enormous intellectual and material resources that must be mobilized to achieve breakthroughs by rational drug design in industry.

Unfortunately, the second part the book, which is concerned with methods, does not fulfill the expectations raised by the first part, especially since it occupies only a third of the whole work. Although the chapters on the co‐crystallization of serin proteases with ecotin, and on the construction of orthogonal receptor--ligand pairs, are certainly very interesting, the rest of the contributions (on structural genomics, microcrystallization, and crystallization by mutagensis) do not provide very rewarding reading, as the choice is unbalanced, and some of them contain little hard information. This part especially confirms the editors\' comment at the beginning that the choice of articles was determined by the availability of authors.

Another unsatisfactory aspect of the book as a whole is the variation from chapter to chapter in the quality and clarity of the structural formulas, which could have been avoided by some editorial work. Also, the book could have been improved by including two or three introductory chapters to give readers with only limited previous knowledge some understanding of the nature and strategies of protein crystallography in pharmaceutical research. However, parts of the book will certainly be very useful for specialists in the area of structure‐based drug design, provided that they do not expect to find here a more method‐orientated collection of articles.
